Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
Year: 2002
Type: article
Study design: Clinical Trial
Source: PubMed
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: intraperitoneal administration, peritoneal carcinomatosis, Müllerian carcinoma, gastrointestinal cancer, peritoneal mesothelioma, dose-limiting toxicity, pharmacokinetics, pharmacodynamics, tumor immunology, tumor cell apoptosis, interferon-gamma, TNF-α, IL-10, peritoneal exudate cells, cytokine therapy
Open Access status: closed
OpenAlex ID: W2171923478
